Old Web
English
Sign In
Acemap
>
authorDetail
>
Beatriz Carmona-Hidalgo
Beatriz Carmona-Hidalgo
Emerald Group Publishing
Endocrinology
Internal medicine
Cannabinoid
Fatty liver
Liver injury
4
Papers
6
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
(+)-trans-Cannabidiol-2-hydroxy pentyl is a dual CB1R antagonist/CB2R agonist that prevents diabetic nephropathy in mice.
2021
Pharmacological Research
Isabel González-Mariscal
Beatriz Carmona-Hidalgo
Matthias Winkler
Juan D. Unciti-Broceta
Alejandro Escamilla
María Gómez-Cañas
Javier Fernández-Ruiz
Bernd L. Fiebich
Silvana-Yanina Romero-Zerbo
Francisco-Javier Bermúdez-Silva
Juan A. Collado
Eduardo Muñoz
Show All
Source
Cite
Save
Citations (2)
Δ9-Tetrahydrocannabinolic Acid markedly alleviates liver fibrosis and inflammation in mice
2021
Phytomedicine
Beatriz Carmona-Hidalgo
Isabel González-Mariscal
Adela García-Martín
María E. Prados
Francisco Ruiz-Pino
Giovanni Appendino
Manuel Tena-Sempere
Eduardo Muñoz
Show All
Source
Cite
Save
Citations (3)
Detrimental Effect of Cannabidiol on the Early Onset of Diabetic Nephropathy in Male Mice
2021
Pharmaceuticals, policy and law
Beatriz Carmona-Hidalgo
Adela García-Martín
Eduardo Muñoz
Isabel González-Mariscal
Show All
Source
Cite
Save
Citations (0)
Δ9-Tetrahydrocannabinolic Acid markedly alleviates liver fibrosis and inflammation in murine models of chemically- and obesity-induced liver injury
2020
bioRxiv
Beatriz Carmona-Hidalgo
Isabel González-Mariscal
Adela García-Martín
Francisco Ruiz-Pino
Giovanni Apendino
Manuel Tena-Sempere
Eduardo Muñoz
Show All
Source
Cite
Save
Citations (1)
1